These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


845 related items for PubMed ID: 11856795

  • 1. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ.
    Blood; 2003 Nov 15; 102(10):3759-64. PubMed ID: 12881316
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Nov 15; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr 15; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, Rajkumar SV.
    Hematol Oncol Clin North Am; 2007 Dec 15; 21(6):1093-113, ix. PubMed ID: 17996590
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ.
    N Engl J Med; 2006 Mar 30; 354(13):1362-9. PubMed ID: 16571879
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
    Kumar S, Rajkumar SV, Kyle RA, Lacy MQ, Dispenzieri A, Fonseca R, Lust JA, Gertz MA, Greipp PR, Witzig TE.
    J Clin Oncol; 2005 Aug 20; 23(24):5668-74. PubMed ID: 16110026
    [Abstract] [Full Text] [Related]

  • 20. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul 20; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.